000 | 01690 a2200469 4500 | ||
---|---|---|---|
005 | 20250517043659.0 | ||
264 | 0 | _c20151023 | |
008 | 201510s 0 0 eng d | ||
022 | _a1558-8238 | ||
024 | 7 |
_a10.1172/JCI80323 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKrishnan, Navasona | |
245 | 0 | 0 |
_aPTP1B inhibition suggests a therapeutic strategy for Rett syndrome. _h[electronic resource] |
260 |
_bThe Journal of clinical investigation _cAug 2015 |
||
300 |
_a3163-77 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xgenetics |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethyl-CpG-Binding Protein 2 _xgenetics |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred CBA |
650 | 0 | 4 | _aMice, Mutant Strains |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aProtein Tyrosine Phosphatase, Non-Receptor Type 1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptor, trkB _xgenetics |
650 | 0 | 4 |
_aRett Syndrome _xdrug therapy |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
700 | 1 | _aKrishnan, Keerthi | |
700 | 1 | _aConnors, Christopher R | |
700 | 1 | _aChoy, Meng S | |
700 | 1 | _aPage, Rebecca | |
700 | 1 | _aPeti, Wolfgang | |
700 | 1 | _aVan Aelst, Linda | |
700 | 1 | _aShea, Stephen D | |
700 | 1 | _aTonks, Nicholas K | |
773 | 0 |
_tThe Journal of clinical investigation _gvol. 125 _gno. 8 _gp. 3163-77 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI80323 _zAvailable from publisher's website |
999 |
_c25112696 _d25112696 |